- Home
- AXSM vs QFIN Comparison
AXSM vs QFIN Comparison
Compare AXSM & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- QFIN
- Stock Information
- Founded
- AXSM 2012
- QFIN 2016
- Country
- AXSM United States
- QFIN China
- Employees
- AXSM N/A
- QFIN N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- QFIN Finance: Consumer Services
- Sector
- AXSM Health Care
- QFIN Finance
- Exchange
- AXSM Nasdaq
- QFIN Nasdaq
- Market Cap
- AXSM 4.0B
- QFIN 3.9B
- IPO Year
- AXSM 2015
- QFIN 2018
- Fundamental
- Price
- AXSM $91.24
- QFIN $25.01
- Analyst Decision
- AXSM Strong Buy
- QFIN Strong Buy
- Analyst Count
- AXSM 14
- QFIN 1
- Target Price
- AXSM $124.57
- QFIN $23.80
- AVG Volume (30 Days)
- AXSM 421.5K
- QFIN 1.9M
- Earning Date
- AXSM 11-04-2024
- QFIN 08-13-2024
- Dividend Yield
- AXSM N/A
- QFIN 4.70%
- EPS Growth
- AXSM N/A
- QFIN 25.79
- EPS
- AXSM N/A
- QFIN 4.12
- Revenue
- AXSM $291,489,000.00
- QFIN $2,351,728,381.00
- Revenue This Year
- AXSM $42.50
- QFIN $4.14
- Revenue Next Year
- AXSM $69.28
- QFIN $3.31
- P/E Ratio
- AXSM N/A
- QFIN $6.02
- Revenue Growth
- AXSM 59.73
- QFIN 9.80
- 52 Week Low
- AXSM $55.02
- QFIN $13.68
- 52 Week High
- AXSM $98.40
- QFIN $26.50
- Technical
- Relative Strength Index (RSI)
- AXSM 55.06
- QFIN 61.26
- Support Level
- AXSM $90.14
- QFIN $24.30
- Resistance Level
- AXSM $96.56
- QFIN $25.39
- Average True Range (ATR)
- AXSM 2.75
- QFIN 0.69
- MACD
- AXSM -0.05
- QFIN -0.23
- Stochastic Oscillator
- AXSM 42.19
- QFIN 35.45
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About QFIN Qifu Technology Inc.
Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.